Abiopharma

🔍 O'Leary George (Executive)

Company: New America Acquisition I Corp. (NWAX)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 50,000 shares of Class B Common Stock at $0.002 per share (Direct)
  Date: 2026-08-26 | Code: J | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Represents the surrender by the Reporting Person of 50,000 Series A Units of New America Sponsor I LLC (the "Sponsor") to the Sponsor pursuant to a Definitive Separation Agreement, dated as of August 26, 2026, between the Sponsor and the Reporting Person. Each Series A Unit of the Sponsor represents an interest in the shares of Class B common stock of the Issuer held by the Sponsor.
• F2: The Series A Units were surrendered for aggregate consideration of $100 (equivalent to $0.002 per underlying share of Class B common stock), representing a return of the capital contribution attributable to the surrendered units.
• F3: Reflects 100,000 shares of Class B common stock of the Issuer underlying 100,000 Series A Units of the Sponsor held by the Reporting Person. Shares of Class B common stock automatically convert into shares of Class A common stock of the Issuer at the time of the Issuer's initial business combination on a one-for-one basis, subject to adjustment. The Reporting Person disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose.